Clinical Trial Update: Ofatumumab, Pentostatin, and Cyclophosphamide in Treating Patients With Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma [Phase 2]

View source ↗

Summary

Phase 2 trial investigating ofatumumab, pentostatin, and cyclophosphamide for untreated chronic lymphocytic leukemia or small lymphocytic lymphoma has completed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia
• Small Lymphocytic Lymphoma

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Ofatumumab (ofatumumab)
• Pentostatin (pentostatin)

Snippet

Sponsor: Mayo Clinic | Conditions: Chronic Lymphocytic Leukemia, Stage 0 Chronic Lymphocytic Leukemia | Phase 2 | Status: COMPLETED | Results posted: 2018-09-18